Suvretta Capital Management, LLC Catalent, Inc. Transaction History

Suvretta Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$100.34 - $115.69 $100 Million - $116 Million	-1,001,290 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$101.51 - $125.27 $3.99 Million - $4.93 Million	39,355 Added 4.09%	1,001,290 $105 Million
Q4 2020 Feb 16, 2021	SELL	$85.88 - $105.36 $15.1 Million - $18.5 Million	-175,425 Reduced 15.42%	961,935 $100 Million
Q3 2020 Nov 16, 2020	BUY	$72.74 - $92.5 $33.6 Million - $42.7 Million	461,260 Added 68.22%	1,137,360 $97.4 Million
Q2 2020 Aug 14, 2020	BUY	$48.02 - $79.04 $32.5 Million - $53.4 Million	676,100 New	676,100 $49.6 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Suvretta Capital Management, LLC with notifications on news.